128 related articles for article (PubMed ID: 31582308)
1. Does microscopic positive tumor margin in papillary thyroid cancer really matter?
Back K; Kim SK; Chai YJ; Kim JH; Choe JH; Kim JS
Surgery; 2019 Dec; 166(6):1160-1167. PubMed ID: 31582308
[TBL] [Abstract][Full Text] [Related]
2. Does microscopically involved margin increase disease recurrence after curative surgery in papillary thyroid carcinoma?
Lang BH; Shek TW; Wan KY
J Surg Oncol; 2016 May; 113(6):635-9. PubMed ID: 26843438
[TBL] [Abstract][Full Text] [Related]
3. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence.
Abraham E; Tran B; Roshan D; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
ANZ J Surg; 2018 Nov; 88(11):1193-1197. PubMed ID: 29701284
[TBL] [Abstract][Full Text] [Related]
4. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
6. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
7. Microscopically positive surgical margins and local recurrence in thyroid cancer. A meta-analysis.
Sanabria A; Rojas A; Arevalo J; Kowalski LP; Nixon I
Eur J Surg Oncol; 2019 Aug; 45(8):1310-1316. PubMed ID: 30795955
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
9. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
[TBL] [Abstract][Full Text] [Related]
10. Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
Llamas-Olier AE; Cuéllar DI; Buitrago G
Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
[TBL] [Abstract][Full Text] [Related]
11. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
12. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
Tsui KP; Kwan WY; Chow TL
Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
Lee SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg; 2019 May; 269(5):966-971. PubMed ID: 29462007
[TBL] [Abstract][Full Text] [Related]
14. Microscopic positive margins strongly predict reduced disease-free survival in pT4a papillary thyroid cancer.
Abraham E; Roshan D; Tran B; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
Head Neck; 2019 Aug; 41(8):2549-2554. PubMed ID: 30860642
[TBL] [Abstract][Full Text] [Related]
15. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
17. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?
Harries V; Wang LY; McGill M; Xu B; Tuttle RM; Wong RJ; Shaha AR; Shah JP; Ghossein R; Patel SG; Ganly I
Surgery; 2020 Jan; 167(1):10-17. PubMed ID: 31515125
[TBL] [Abstract][Full Text] [Related]
18. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
19. Microscopic Positive Tumor Margin Does Not Increase the Risk of Recurrence in Patients with T1-T2 Well-Differentiated Thyroid Cancer.
Kluijfhout WP; Pasternak JD; Kwon JS; Lim J; Shen WT; Gosnell JE; Khanafshar E; Duh QY; Suh I
Ann Surg Oncol; 2016 May; 23(5):1446-51. PubMed ID: 26628431
[TBL] [Abstract][Full Text] [Related]
20. Right posterior paratracheal lymph nodes metastasis is one of the predictive factors in right-sided papillary thyroid carcinoma.
Kim D; Kwon HK; Shin SC; Sung ES; Jeon YK; Kim BH; Kim IJ; Lee JC; Lee BJ
Surgery; 2019 Dec; 166(6):1154-1159. PubMed ID: 31444006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
